A Healthy Dose! 4 midcap pharma stocks with upside potential of up to 36%

Textile is one of the oldest industrial sectors in India. However, right from labour issues to smaller Asian countries becoming more competitive in terms of cost of production, different segments of the textile industry have faced more headwinds than tailwinds in their history of existence. This list is drawn from Stock Reports Plus, powered by Refinitiv, with over 4,000 listed stocks along with detailed company analysis focusing on five key components - earnings, fundamentals, relative valuation, risk and price momentum.

While the focus of news stays ACC and Ambuja, it would be better to look at many other players, some of them in mid and small cap space. Some of them have improved their performance in terms of operational efficiency. The list is based on upside estimated by the analysts, with the highest potential stock coming on the top of the list.

Gone are the days, when a single company was considered a bellwether for IT sector stock. Today, whether it is a large or mid sized company, all have different focus areas and hence their quarterly results tend to differ from one another. Stock Reports Plus, powered by Refinitiv, is a comprehensive research report that evaluates five key components of 4,000+ listed stocks - earnings, fundamentals, relative valuation, risk and price momentum to generate standardized scores.

However if one looks at the history of financial markets, there are phases where multiple challenges have come up for the sector at the sametime. But given the savings matrix which Indian’s have, despite all that may have happened, on an overall basis the financial services industry has grown and some select stocks have given decent returns to their shareholders.

When valuations are high but sentiments are bullish, it would be better to add the word “ caution” to your portfolio. Now how does one do it ? By putting some quantitative parameters when making a decision to buy a stock. Refinitiv’s Stock Report Plus which lists stocks with high upside potential over the next 12 months, having an average recommendation rating of “buy” or strong buy .

Capital good companies had faced tough times for many years. Given the fact that hardly any capacity buildup was taking place in any industry, a number had to change their product portfolio and had to live with very low margins. But all the efforts have now started to show some results. Given the performance of the stock, a large majority of these stocks have hold recommendations from the analysts.

Pharma stocks had been underperforming for a very long time. Some time USFDA issues, at other instances of pricing pressure in US markets have been troubling the sector. However some tailwinds have emerged recently, shortage in some segments in the generic market in the US have led to sharp spikes in prices. The list is based on upside estimated by the analysts, with the highest potential stock coming on the top of the list.

Last three weeks have seen a sharper correction both in terms of what nifty and sensex have witnessed but also in terms of market breadth coming underpressure. Now because this correction is coming at a time, when some events risks are on the domestic front and also because of developments in the US. It would be better that caution should be added to the decision making in the stock market. ET screener powered by Refinitiv’s Stock Report Plus applies different algorithms & filters to all BSE and NSE stocks, and lists stocks which fulfill the various criteria as specified into the algorithms & filters to find those which might help navigate the stock market.